Prognostic indicators in an aggressive pituitary Crooke's cell adenoma

Canadian Journal of Neurological Sciences

Volumn 32, Issue 4, 2005, Pages 540-545

  Kovacs, K ^a   Diep, C C ^a   Horvath, E ^a   Cusimano, M ^a   Smyth, H ^a   Coire, C ^b   Lombardero, M ^c   Scheithauer, B W ^d   Lloyd, R V ^d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b Trillium Health Centre Missassauga   (Canada)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CD34 ANTIGEN; CELL MARKER; CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; HYDROCORTISONE; KI 67 ANTIGEN; LUTEINIZING HORMONE; PROLACTIN; THYROTROPIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; CROOKE CELL ADENOMA; CUSHING DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 29044438414     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100004583     Document Type: Article

References (32)

1. Wagermark J, Wersall J. Ultrastructural features of Crooke's changes in pituitary basophil cells. Acta Pathol Microbiol Scand 1968; 72:367-375.
2. Halmi NS, McCormick WF, Decker DA Jr. The natural history of hyalinization of ACTH-MSH cells in man. Arch Path 1971; 91:318-326.
3. DeCicco FA, Dekker A, Yunis EJ. Fine structure of the Crooke's hyaline change in the human pituitary gland. Arch Pathol 1972; 94:65-70.
4. Felix IA, Horvath E, Kovacs K. Massive Crooke's hyalinization in corticotroph cell adeomas of the human pituitary. A histological, immunocytological, and electron microscopic study of three cases. Acta Neurochir 1981; 58:235-243.
5. Horvath E, Kovacs K, Josse R. Pituitary corticotroph cell adenoma with marked abundance of microfilaments. Ultrastruct Pathol 1983; 5:249-255.
6. Neumann PE, Horoupian DS, Goldman JE, Hess MA. Cytoplasmic filaments of Crooke's hyaline change belong to the cytokeratin class. An immunocytochemical and ultrastructural study. Am J Pathol 1984; 116:214-222.
7. Kovacs K. The pathology of Cushing's disease. J Steroid Biochem Mol Biol 1993; 45:179-182.
8. Kovacs K, Horvath E, Stefaneanu L, et al. Two cases of pituitary Crooke's cell adenoma without Cushing's disease: a histologic, immunocytochemical, electron microscopic and in situ hybridization study. Endocr Pathol 1999; 10:65-72.
9. George DH, Scheithauer BW, Kovacs K, et al. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol 2003; 27:1330-1336.
10. Kovacs K, Stefaneanu L, Horvath et al. Prolactin-producing pituitary tumor: resistance to dopamine agonist therapy. J Neurosurg 1995; 82:886-890.
11. Kovacs K, Giannini C, Scheithauer BW, et al. Pituitary changes in Ataxia-telangiectasia syndrome: an immunocytochemical, in situ hybridization, and DNA cytometric study of three cases. Endocr Pathol 1997; 8:195-203.
12. Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW. Vasculature in non-tumorous hypophyses, pituitary adenomas, and carcinomas: a quantitative morphologic study. Endocr Pathol 1995; 6:115-124.
13. Vidal S, Scheithauer BW, Kovacs K. Vascularity in nontumorous human pituitaries and incidental microadenomas: a morphometric study. Endocr Pathol. 2000; 11:215-227.
14. Vidal S, Kovacs K, Horvath E, et al. Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 2001; 438:595-602.
15. Thapar K, Yamada Y, Scheithauer BW, et al. Assessment of mitotic activity in pituitary adenomas and carcinomas. Endocr Pathol 1996; 7:215-221.
16. Vidal S, Kovacs K, Bell D, et al. Cyclooxygenase-2 expression in human pituitary tumors. Cancer 2003; 97:2814-2821.
17. Crooke AC. A change in the basophil cells of the pituitary gland common to conditions which exhibit the syndrome attributed to basophil adenoma. J Pathol Bacteriol 1935; 41:339-349
18. Horvath E, Scheithauer BW, Kovacs K, Lloyd RV. Hypothalamus and pituitary. In: Graham DI, Lantos PL (Eds). Greenfield's Neuropathology Vol 1, (7th Ed), New York Arnold Publi, NY; 2002:983-1062.
19. Ikeda H, Yoshimoto T, Ogawa Y, Mizoi K, Murakami O. Clinicopathological study of Cushing's disease with large pituitary adenoma. Clin Endocrinol 1997; 46:669-679.
20. Thapar K, Kovacs K, Scheithauer BW, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 1996; 38:99-106.
21. Kovacs K, Scheithauer BW, Horvath E, Lloyd RV. The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme. Cancer 1996; 78:502-510.
22. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 1996; 38:765-770.
23. Jin L, Qian X, Kulig E, et al. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol 1997; 151:509-519.
24. Lidhar R, Korbonits M, Jordan S, et al. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. J Clin Endocrinol Metab 1999; 84:3823-3830.
25. Vidal S, Kovacs K, Horvath E et al. Topoisomerase II alpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior. Mod Pathol 2002; 15:1205-1212.
26. Riss D, Jin L, Qian X, et al. Differential expression of galectin-3 in pituitary tumors. Cancer Res 2003; 63:2251-2255.
27. Lloyd RV, Scheithauer BW, Kuroki T, et al. Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol 1999; 10:229-235.
28. Vidal S, Kovacs K, Cohen SM et al. Localization of vascular endothelial growth factor in nontumorous human pituitaries. Endocr Pathol 1999; 10:109-122.
29. Yamamoto T, Nishizawa Y, Tsuji M, et al. Expression of vascular endothelial growth factor in normal pituitary cells and pituitary adenomas producing adrenocorticotropic hormone. Endocr Pathol 1999; 10:157-164.
30. de la Torre NG, Wass JA, Turner HE. Morphologic changes and molecular regulation of angiogenesis in pituitary adenomas. Front Horm Res 2004; 32:133-145.
31. Kovacs K, Rotondo F, Stefaneanu L, et al. Glucocorticoid receptor expression in nontumorous human pituitaries and pituitary adenomas. Endocr Pathol 2000; 11:267-276.
32. Gaffey TA, Scheithauer BW, Lloyd RV, et al. Corticotroph carcinoma of the pituitary: a clinicopathological study. Report of four cases. J Neurosurg 2002; 96:352-360.